Roche Palo Alto LLC v. Ranbaxy Laboratories Ltd.

455 F. App'x 963
CourtCourt of Appeals for the Federal Circuit
DecidedAugust 24, 2010
DocketNos. 2010-1056, 2010-1101
StatusPublished

This text of 455 F. App'x 963 (Roche Palo Alto LLC v. Ranbaxy Laboratories Ltd.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Roche Palo Alto LLC v. Ranbaxy Laboratories Ltd., 455 F. App'x 963 (Fed. Cir. 2010).

Opinion

ON MOTION

ORDER

Upon consideration of the parties’ joint motion to remand this ease, Roche Palo Alto LLC v. Ranbaxy Laboratories Limited and Ranbaxy. Inc., to the United States District Court for the District of New Jersey, case no. 06-CV-2003, for further proceedings consistent with the settlement agreement reached by the parties, and specifically to allow the District Court to consider granting the parties’ motion for vacatur,

IT IS ORDERED THAT:

(1) The motion is granted.

(2) Each side shall bear its own costs.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
455 F. App'x 963, Counsel Stack Legal Research, https://law.counselstack.com/opinion/roche-palo-alto-llc-v-ranbaxy-laboratories-ltd-cafc-2010.